{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T12:26:07Z","timestamp":1773404767458,"version":"3.50.1"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Chromatography A"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1016\/j.chroma.2014.12.065","type":"journal-article","created":{"date-parts":[[2014,12,30]],"date-time":"2014-12-30T02:31:39Z","timestamp":1419906699000},"page":"177-185","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":61,"special_numbering":"C","title":["Quality by design in the chiral separation strategy for the determination of enantiomeric impurities: Development of a capillary electrophoresis method based on dual cyclodextrin systems for the analysis of levosulpiride"],"prefix":"10.1016","volume":"1380","author":[{"given":"S.","family":"Orlandini","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Pasquini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Del Bubba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Pinzauti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Furlanetto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.chroma.2014.12.065_bib0305","series-title":"Harmonised Tripartite Guideline. Pharmaceutical Development Q8(R2). International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use","author":"ICH","year":"2009"},{"key":"10.1016\/j.chroma.2014.12.065_bib0310","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s00216-012-6302-2","article-title":"Application of quality by design to the development of analytical separation methods","volume":"405","author":"Orlandini","year":"2013","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.chroma.2014.12.065_bib0315","series-title":"Pharmaceutical Experimental Design","author":"Lewis","year":"1999"},{"key":"10.1016\/j.chroma.2014.12.065_bib0320","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1002\/jps.22325","article-title":"Development of quality-by-design analytical methods","volume":"100","author":"Vogt","year":"2011","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.chroma.2014.12.065_bib0325","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/j.jpba.2010.11.018","article-title":"Fundamental aspects of chiral electromigration techniques and application in pharmaceutical and biomedical analysis","volume":"55","author":"Scriba","year":"2011","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.chroma.2014.12.065_bib0330","doi-asserted-by":"crossref","first-page":"3552","DOI":"10.1002\/elps.200800081","article-title":"Strategies in method development to quantify enantiomeric impurities using CE","volume":"29","author":"El Deeb","year":"2008","journal-title":"Electrophoresis"},{"key":"10.1016\/j.chroma.2014.12.065_bib0335","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.chroma.2007.08.008","article-title":"Enantioseparations by using capillary electrophoretic techniques: the story of 20 and a few more years","volume":"1168","author":"Chankvetadze","year":"2007","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.chroma.2014.12.065_bib0340","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.chroma.2008.07.071","article-title":"Chiral separation by electromigration techniques","volume":"1204","author":"G\u00fcbitz","year":"2008","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.chroma.2014.12.065_bib0345","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.jpba.2013.06.013","article-title":"Improved quality-by-design compliant methodology for method development in reversed-phase liquid chromatography","volume":"84","author":"Debrus","year":"2013","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.chroma.2014.12.065_bib0350","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.jpba.2013.09.030","article-title":"Robust method optimization strategy \u2013 a useful tool for method transfer: the case of SFC","volume":"88","author":"Dispas","year":"2014","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.chroma.2014.12.065_bib0355","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.jpba.2013.09.026","article-title":"Improvement of a stability-indicating method by quality-by-design versus quality-by-testing: a case of a learning process","volume":"88","author":"Hubert","year":"2014","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.chroma.2014.12.065_bib0360","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.chroma.2011.12.041","article-title":"Quality by design: multidimensional exploration of the design space in high performance liquid chromatography method development for better robustness before validation","volume":"1232","author":"Monks","year":"2012","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.chroma.2014.12.065_bib0365","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.jpba.2013.12.023","article-title":"In silico robustness testing of a compendial HPLC purity method by using of a multidimensional design space build by chromatography modeling \u2013 case study pramipexole","volume":"91","author":"Schmidt","year":"2014","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.chroma.2014.12.065_bib0370","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.jpba.2013.02.028","article-title":"Exploring better column selectivity choices in ultra-high performance liquid chromatography using quality by design principles","volume":"80","author":"Korm\u00e1ny","year":"2013","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.chroma.2014.12.065_bib0375","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.talanta.2012.03.064","article-title":"Mixture-process variable approach to optimize a microemulsion electrokinetic chromatography method for the quality control of a nutraceutical based on coenzyme Q10","volume":"97","author":"Piepel","year":"2012","journal-title":"Talanta"},{"key":"10.1016\/j.chroma.2014.12.065_bib0380","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.jpba.2013.04.014","article-title":"Multivariate optimization of capillary electrophoresis methods: a critical review","volume":"87","author":"Orlandini","year":"2014","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.chroma.2014.12.065_bib0385","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.aca.2013.10.005","article-title":"Quality by design approach in the development of a solvent-modified micellar electrokinetic chromatography method: finding the design space for the determination of amitriptyline and its impurities","volume":"802","author":"Furlanetto","year":"2013","journal-title":"Anal. Chim. Acta"},{"key":"10.1016\/j.chroma.2014.12.065_bib0390","doi-asserted-by":"crossref","first-page":"2538","DOI":"10.1002\/elps.201400173","article-title":"Analytical quality by design in the development of a cyclodextrin-modified capillary electrophoresis method for the assay of metformin and its related substances","volume":"35","author":"Orlandini","year":"2014","journal-title":"Electrophoresis"},{"key":"10.1016\/j.chroma.2014.12.065_bib0395","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1002\/elps.201100528","article-title":"Quantitative impurity analysis of monoclonal antibody size heterogeneity by CE-LIF: example of development and validation through a quality-by-design framework","volume":"33","author":"Michels","year":"2012","journal-title":"Electrophoresis"},{"key":"10.1016\/j.chroma.2014.12.065_bib0400","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.jpba.2012.10.015","article-title":"Implementation of a design space approach for enantiomeric separations in polar organic solvent chromatography","volume":"74","author":"Nistor","year":"2013","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.chroma.2014.12.065_bib0405","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1177\/106002809502900210","article-title":"Sulpiride: an antipsychotic with selective dopaminergic antagonist properties","volume":"29","author":"Caley","year":"1995","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.chroma.2014.12.065_bib0410","series-title":"Martindale: The Complete Drug Reference","first-page":"342","year":"2005"},{"key":"10.1016\/j.chroma.2014.12.065_bib0415","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/1043-6618(95)80052-2","article-title":"Pharmacotoxicological aspects of levosulpiride","volume":"31","author":"Rossi","year":"1995","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.chroma.2014.12.065_bib0420","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/1043-6618(95)80053-0","article-title":"Levosulpiride: a review of its clinical use in psychiatry","volume":"31","author":"Mucci","year":"1995","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.chroma.2014.12.065_bib0425","doi-asserted-by":"crossref","first-page":"288","DOI":"10.2165\/00002018-199614050-00003","article-title":"A risk-benefit assessment of sulpiride in the treatment of schizophrenia","volume":"14","author":"Mauri","year":"1996","journal-title":"Drug Saf."},{"key":"10.1016\/j.chroma.2014.12.065_bib0430","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1002\/bdd.2510140603","article-title":"Disposition of enantiomers of sulpiride in humans and rats","volume":"14","author":"Kamizono","year":"1993","journal-title":"Biopharm. Drug Dispos."},{"key":"10.1016\/j.chroma.2014.12.065_bib0435","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1055\/s-2001-15194","article-title":"Serum levels of sulpiride enantiomers after oral treatment with racemic sulpiride in psychiatric patients: a pilot study","volume":"34","author":"M\u00fcller","year":"2001","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.chroma.2014.12.065_bib0440","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.3724\/SP.J.1123.2012.07035","article-title":"Chiral separation of benzamide antipsychotics and determination of their enantiomers by high performance liquid chromatography","volume":"30","author":"Wang","year":"2012","journal-title":"Chin. J. Chromatogr. (Se Pu)"},{"key":"10.1016\/j.chroma.2014.12.065_bib0445","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/j.cclet.2013.05.019","article-title":"Enantiomeric separations of four basic drugs containing N-alkyl groups by a RP-HPLC system using SBE-\u03b2-CD as chiral mobile phase additive","volume":"24","author":"Huang","year":"2013","journal-title":"Chin. Chem. Lett."},{"key":"10.1016\/j.chroma.2014.12.065_bib0450","first-page":"121","article-title":"Chiral separation of sulpiride by reversed-phase high performance liquid chromatography","volume":"23","author":"Wang","year":"2004","journal-title":"J. Instrum. Anal."},{"key":"10.1016\/j.chroma.2014.12.065_bib0455","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.apsb.2012.06.006","article-title":"High performance liquid chromatographic separation of eight drugs collected in Chinese Pharmacopoeia 2010 on amylase ramification chiral stationary phase","volume":"2","author":"Wang","year":"2012","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.chroma.2014.12.065_bib0460","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S1570-0232(01)00582-7","article-title":"Supercritical fluid chromatography coupled to electrospray mass spectrometry: a powerful tool for the analysis of chiral mixtures","volume":"770","author":"Garzotti","year":"2002","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.chroma.2014.12.065_bib0465","doi-asserted-by":"crossref","first-page":"2567","DOI":"10.1002\/elps.200305485","article-title":"Enantioseparations of basic and bifunctional pharmaceuticals by capillary electrochromatography using polysaccharide stationary phases","volume":"24","author":"Mangelings","year":"2003","journal-title":"Electrophoresis"},{"key":"10.1016\/j.chroma.2014.12.065_bib0470","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1002\/bmc.3072","article-title":"Three versus five micrometer chlorinated polysaccharide-based packings in chiral capillary electrochromatography: performance evaluation","volume":"28","author":"Hendrickx","year":"2014","journal-title":"Biomed. Chromatogr."},{"key":"10.1016\/j.chroma.2014.12.065_bib0475","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0021-9673(01)01573-4","article-title":"Screening approach for chiral separation of pharmaceuticals: Part I. Normal-phase liquid chromatography","volume":"947","author":"Perrin","year":"2002","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.chroma.2014.12.065_bib0480","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.chroma.2004.04.040","article-title":"Definition and system implementation of strategies for method development of chiral separations in normal- or reversed-phase liquid chromatography using polysaccharide-based stationary phases","volume":"1041","author":"Matthijs","year":"2004","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.chroma.2014.12.065_bib0485","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.jpba.2011.02.015","article-title":"Chiral separations in normal phase liquid chromatography: enantioselectivity of recently commercialized polysaccharide-based selectors. Part I: enantioselectivity under generic screening conditions","volume":"55","author":"Younes","year":"2011","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.chroma.2014.12.065_bib0490","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.chroma.2004.12.038","article-title":"Screening approach for chiral separation of pharmaceuticals: Part III. Supercritical fluid chromatography for analysis and purification in drug discovery","volume":"1088","author":"Maftouh","year":"2005","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.chroma.2014.12.065_bib0495","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.chroma.2006.01.106","article-title":"Screening approach for chiral separation of pharmaceuticals IV. Polar organic solvent chromatography","volume":"1111","author":"Matthijs","year":"2006","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.chroma.2014.12.065_bib0500","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1002\/jssc.200500515","article-title":"Chiral separation strategy in polar organic solvent chromatography and performance comparison with normal-phase liquid and supercritical-fluid chromatography","volume":"29","author":"Matthijs","year":"2006","journal-title":"J. Sep. Sci."},{"key":"10.1016\/j.chroma.2014.12.065_bib0505","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1016\/j.chroma.2010.12.117","article-title":"Open tubular capillary columns with basic templates made by the generalized preparation protocol in capillary electrochromatography chiral separation and template structural effects on chiral separation capability","volume":"1218","author":"Zaidi","year":"2011","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.chroma.2014.12.065_bib0510","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/S0731-7085(00)00356-3","article-title":"Chiral analysis of selected dopamine receptor antagonists in serum using capillary electrophoresis with cyclodextrin additives","volume":"23","author":"Xu","year":"2000","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.chroma.2014.12.065_bib0515","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.aca.2004.07.031","article-title":"Electrophoretic separation strategy for chiral pharmaceuticals using highly sulfated and neutral cyclodextrins based dual selector systems","volume":"525","author":"Matthijs","year":"2004","journal-title":"Anal. Chim. Acta"},{"key":"10.1016\/j.chroma.2014.12.065_bib0520","first-page":"421","article-title":"Separation of neutral and basic enantiomers by cyclodextrin electrokinetic chromatography using anionic cyclodextrin derivatives as chiral pseudo-stationary phases","volume":"19","author":"Tanaka","year":"1996","journal-title":"J. Sep. Sci."},{"key":"10.1016\/j.chroma.2014.12.065_bib0525","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1002\/ardp.19873200916","article-title":"Physical properties of sulpiride and its (S)-enantiomer","volume":"320","author":"Pitr\u00e9","year":"1987","journal-title":"Arch. Pharm."},{"key":"10.1016\/j.chroma.2014.12.065_bib0530","first-page":"110","article-title":"enantioseparation of sulpiride: evaluation of levosulpiride optical purity","volume":"131","author":"Celentano","year":"1992","journal-title":"Boll. Chim. Farm."},{"key":"10.1016\/j.chroma.2014.12.065_bib0535","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/BF02466445","article-title":"Separation of the enantiomers of basic drugs by affinity capillary electrophoresis using a partial filling technique and \u03b11-acid glycoprotein as chiral selector","volume":"44","author":"Tanaka","year":"1997","journal-title":"Chromatographia"},{"key":"10.1016\/j.chroma.2014.12.065_bib0540","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.trac.2012.09.007","article-title":"Design spaces for analytical methods","volume":"42","author":"Rozet","year":"2013","journal-title":"Trends Anal. Chem."},{"key":"10.1016\/j.chroma.2014.12.065_bib0545","series-title":"Harmonised Tripartite Guideline. Validation of Analytical Procedures: Text and Methodology Q2(R1). International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use","author":"ICH","year":"2005"},{"key":"10.1016\/j.chroma.2014.12.065_bib0550","unstructured":"D. Mathieu, J. Nony, R. Phan-Tan-Luu, NEMROD-W, LPRAI sarl, Marseille."},{"key":"10.1016\/j.chroma.2014.12.065_bib0555","unstructured":"MODDE v. 10, MKS Umetrics AB, Sweden."},{"key":"10.1016\/j.chroma.2014.12.065_bib0560","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1002\/elps.200600380","article-title":"Development of a CZE method for the determination of mizolastine and its impurities in pharmaceutical preparations using response surface methodology","volume":"28","author":"Orlandini","year":"2007","journal-title":"Electrophoresis"},{"key":"10.1016\/j.chroma.2014.12.065_bib0565","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0021-9673(99)01309-6","article-title":"Enantioselective determination by capillary electrophoresis with cyclodextrins as chiral selectors","volume":"875","author":"Fanali","year":"2000","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.chroma.2014.12.065_bib0570","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1002\/elps.200700657","article-title":"The role of cyclodextrins in chiral capillary electrophoresis","volume":"29","author":"Juvancz","year":"2008","journal-title":"Electrophoresis"},{"key":"10.1016\/j.chroma.2014.12.065_bib0575","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0021-9673(00)00084-4","article-title":"Enantiomeric separations of drugs using mixtures of charged and neutral cyclodextrins","volume":"875","author":"Fillet","year":"2000","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.chroma.2014.12.065_bib0580","series-title":"What is Total Quality Control? The Japanese Way","author":"Ishikawa","year":"1985"},{"key":"10.1016\/j.chroma.2014.12.065_bib0585","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/S0731-7085(98)00067-3","article-title":"Development and validation of a differential pulse polarographic method for quinolinic acid determination in human plasma and urine after solid-phase extraction: a chemometric approach","volume":"17","author":"Furlanetto","year":"1998","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.chroma.2014.12.065_bib0590","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.chroma.2007.12.029","article-title":"Identification and determination of mainstream and sidestream smoke components in different brands and types of cigarettes by means of solid-phase microextraction\u2013gas chromatography\u2013mass spectrometry","volume":"1180","author":"Pieraccini","year":"2008","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.chroma.2014.12.065_bib0595","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.chemolab.2005.04.010","article-title":"Estimation of the uncertainty of indirect measurements from the propagation of distributions by using the Monte-Carlo method: an overview","volume":"79","author":"Herrador","year":"2005","journal-title":"Chemom. Intell. Lab. Syst."},{"key":"10.1016\/j.chroma.2014.12.065_bib0600","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1007\/s00216-003-2189-2","article-title":"How experimental design can improve the validation process. Studies in pharmaceutical analysis","volume":"377","author":"Furlanetto","year":"2003","journal-title":"Anal. Bioanal. Chem."}],"container-title":["Journal of Chromatography A"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021967314019979?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021967314019979?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,26]],"date-time":"2018-09-26T12:31:32Z","timestamp":1537965092000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021967314019979"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2]]},"references-count":60,"alternative-id":["S0021967314019979"],"URL":"https:\/\/doi.org\/10.1016\/j.chroma.2014.12.065","relation":{},"ISSN":["0021-9673"],"issn-type":[{"value":"0021-9673","type":"print"}],"subject":[],"published":{"date-parts":[[2015,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Quality by design in the chiral separation strategy for the determination of enantiomeric impurities: Development of a capillary electrophoresis method based on dual cyclodextrin systems for the analysis of levosulpiride","name":"articletitle","label":"Article Title"},{"value":"Journal of Chromatography A","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.chroma.2014.12.065","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}